An observational study in Minimally Invasive Surgical Procedures and Colon Cancer Patients, sponsored by Hospital Central de la Defensa Gómez Ulla. Recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-25.
Sponsored by Hospital Central de la Defensa Gómez Ulla · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 86 studies in Pain, Postoperative with a site in Spain — 18 open to participants now, 23 under way, 1 of them phase 3. Pain, Postoperative · Spain.
Among the 86 studies in Pain, Postoperative with a site in Spain, this one is the 19th largest by planned enrollment of the 26 observational ones that give a count, is one of 6 that started in 2025, is one of 26 observational ones, reaches primary completion later than 11 of the 22 other live ones, and was the 76th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →18 of the 86 studies in Pain, Postoperative with a site in Spain are open now. Recruiting first, the newest first:
Universitat Internacional de Catalunya · Sites in Spain
Ages 18+ · Healthy volunteers
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Sites in Spain
Ages 18+
Fundacin Biomedica Galicia Sur · Sites in Spain
Ages 18+ · Healthy volunteers
Universitat Internacional de Catalunya · Sites in Spain
Ages 18+
Hospital Universitario de Gran Canaria Doctor Negrín · Sites in Spain
Ages 18+
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
86 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 3 · Phase 3 13 · Phase 4 14
First in 2001; this study’s year is marked. 6 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 80 is below the median of 102 across 685 observational studies indexed under Pain, Postoperative.
Median enrollment 90 across the 60 interventional studies, 106 across the 26 observational. Of the 55 that completed or were terminated, 8 (15%) have results posted.
This tab as a report to print or save as PDF → With an account.
11 of 86 have an industry lead sponsor. The 10 most frequent:
Hospital Central de la Defensa Gómez Ulla is the lead sponsor of 4 studies on the registry; 1 is open to participants now.
Hospital Central de la Defensa Gómez Ulla has 1 study filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
5 of the studies in Pain, Postoperative with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07193472Hospital del Rio HortegaSerratus Intercostal Plane Block Versus Port Infiltration in Laparoscopic Cholecystectomy | 2026-12-31 |
| NCT06638437University Rovira i VirgiliPrevention of Postsurgical Chronic Pain in Children and Adolescents (PREVENDOL) | 2027-06-30 |
| NCT07943299Cardenal Herrera UniversityPatient Experience Across Dental Implant Drilling Protocols | 2027-07 |
| NCT07377370Universitat Internacional de CatalunyaFactors Influencing Postoperative Pain After Gingival Graft Harvesting | 2027-07 |
| NCT05920382Consorci Sanitari de l'Alt Penedès i GarrafRadiofrequency Ablation for the Treatment of Post-knee Arthroplasty Chronic Pain. | 2027-09-01 |
Add all 5 to your calendar (.ics) → With an account.
Among the 86 studies in Pain, Postoperative with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Minimally invasive surgery for colorectal conditions, such as laparoscopic or robotic surgery, has been shown to offer benefits over traditional open surgery. These benefits include less pain after surgery, shorter hospital stays, and fewer complications.
This study aims to compare two types of minimally invasive surgery-laparoscopic and robotic surgery-to determine which approach results in less postoperative pain for patients undergoing colon or rectal surgery. The central hypothesis is that robotic surgery, due to its higher precision and reduced tissue trauma, will lead to lower pain levels after surgery.
The study will enroll adult patients scheduled for elective colorectal surgery at the Hospital General Universitario Gregorio Marañón in Madrid. Participants will undergo either laparoscopic or robotic surgery based on clinical availability and surgical planning, as long as they meet all inclusion criteria under the hospital's enhanced recovery protocol (RICA program).
Researchers will assess patients' pain levels at different time points after surgery (immediately after recovery, at 24, 48, and 72 hours, and at discharge) using validated pain scales. The use of pain medications, hospital stay duration, complication rates, and quality of life up to 12 months after surgery will also be measured.
All patient data will be collected anonymously using a secure electronic system (REDCap). The study will last approximately 2 years and include about 80 patients (40 in each group).
The results could help surgeons and hospitals choose the most effective surgical approach to reduce postoperative pain and improve patient recovery in colorectal surgery.
This is a prospective, single-center, observational study conducted at the Hospital General Universitario Gregorio Marañón in Madrid, Spain. The study compares postoperative pain outcomes in patients undergoing elective colorectal surgery via two different minimally invasive surgical approaches: laparoscopic and robotic-assisted surgery.
Eligible participants will be adults (≥18 years) undergoing elective colon or rectal surgery for benign or malignant disease, provided they meet the criteria of the hospital's Enhanced Recovery After Surgery (ERAS) program, known locally as the RICA protocol. Patients with open surgery indications, chronic analgesic use, or other exclusion criteria (e.g., inflammatory bowel disease, multivisceral resections, chronic opioid use, or inability to follow the RICA protocol) will not be included.
Pain will be assessed using the Visual Analog Scale (VAS) at standardized time points: on arrival at the post-anesthesia care unit, upon admission to the surgical ward, and at 24, 48, and 72 hours postoperatively, as well as at discharge. Intraoperative nociception will also be evaluated using the Nociception Level Index (NOL), an objective measure that reflects the patient's pain response during surgery.
Additional outcomes include postoperative opioid consumption, length of hospital stay, complication rates (using the Clavien-Dindo classification), hospital readmissions, reintervention rates, and patient-reported quality of life measures at 1, 3, 6, and 12 months after surgery, using validated questionnaires (QLQ-C30, QLQ-CR29, and EQ-5D).
Data will be collected and stored securely using the REDCap electronic data capture system, ensuring patient confidentiality. The estimated sample size is 80 patients (approximately 40 in each group), and the total study duration is expected to be 2 years for recruitment and follow-up, with an additional period for data analysis and publication.
The goal is to generate high-quality evidence to help guide clinical decision-making in the selection of surgical approaches for colorectal surgery, focusing on reducing postoperative pain and enhancing recovery.
Adult patients (≥18 years) undergoing elective colorectal surgery (right or left colon resection) for malignant disease at the Hospital General Universitario Gregorio Marañón (Madrid, Spain), following the hospital's Enhanced Recovery After Surgery (ERAS) protocol (RICA program). All participants must meet strict inclusion criteria, including cognitive capacity and ASA I-III classification, and must consent to participate. Patients will receive either laparoscopic or robotic surgical approach based on surgical planning and equipment availability. The study will exclude individuals with prior chronic opioid use, certain comorbidities, or those requiring open surgery or multivisceral resection.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Laparoscopic procedure
Robotic Procedure
Postoperative Pain
Assessment of patient-reported postoperative pain at 24 hours after surgery, using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain).
Time frame: 24 hours
Postoperative Pain at 48 Hours Measured by Visual Analog Scale (VAS)
Assessment of patient-reported postoperative pain at 48 hours after surgery, using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain).
Time frame: 48 hours post-surgery
Postoperative Pain at 72 Hours Measured by Visual Analog Scale (VAS)
Assessment of patient-reported postoperative pain at 72 hours after surgery, using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain).
Time frame: 72 hours post-surgery
Intraoperative Analgesic Consumption
Total intraoperative consumption of opioids (fentanyl and remifentanil), recorded in micrograms, as an indirect measure of nociception and analgesic requirements during surgery.
Time frame: Intraoperative period
Postoperative Analgesic Consumption
Total amount and type of analgesic medication administered during the postoperative hospital stay, including both scheduled and rescue analgesia.
Time frame: From recovery room admission up to 72 hours after surgery.
Postoperative Morbidity (Clavien-Dindo Classification)
Incidence and severity of postoperative complications up to 30 days after surgery, categorized according to the Clavien-Dindo classification system. Patients without complications will be recorded as Grade 0. Complications will be graded from Grade I (minor deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic, or radiological interventions) to Grade V (death of the patient). The minimum possible value is 0 and the maximum possible value is V. Higher grades reflect greater severity of complications and therefore worse clinical outcomes.
Time frame: Within 30 days after surgery
Conversion Rate to Open Surgery
Number and percentage of patients requiring conversion from laparoscopic or robotic approach to open surgery during the procedure.
Time frame: Intraoperative period
Postoperative Inflammatory Response
Measurement of postoperative systemic inflammatory markers including C-reactive protein (CRP), at predefined postoperative time points (e.g., 24h and 48h).
Time frame: Within the first 48 hours post-surgery
Quality of Life (QoL) After Surgery
Assessment of patient-reported quality of life using questionnaire EORTC QLQ-C30
Time frame: 1 month post-surgery
Quality of Life (QoL) After Surgery
Assessment of patient-reported quality of life using questionnaire EORTC QLQ-C30
Time frame: 3 month post-surgery
Quality of Life (QoL) After Surgery
Assessment of patient-reported quality of life using questionnaire EORTC QLQ-C30
Time frame: 6 month post-surgery
Postoperative Inflammatory Response
Measurement of postoperative systemic inflammatory markers including procalcitonin at predefined postoperative time points (e.g., 24h and 48h).
Time frame: Within the first 48 hours post-surgery
Quality of Life (QoL) After Surgery
Assessment of patient-reported quality of life using questionnaire EORTC QLQ-CR29
Time frame: 1 month post-surgery
Quality of Life (QoL) After Surgery
Assessment of patient-reported quality of life using questionnaire EORTC QLQ-CR29
Time frame: 3 month post-surgery
Quality of Life (QoL) After Surgery
Assessment of patient-reported quality of life using questionnaire EORTC QLQ-CR29
Time frame: 6 month post-surgery
Quality of Life (QoL) After Surgery
Assessment of patient-reported quality of life using questionnaire EQ5D
Time frame: 1 month post-surgery
Quality of Life (QoL) After Surgery
Assessment of patient-reported quality of life using questionnaire EQ5D
Time frame: 3 month post-surgery
Quality of Life (QoL) After Surgery
Assessment of patient-reported quality of life using questionnaire EQ5D
Time frame: 6 month post-surgery
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No — Individual participant data (IPD) will not be shared due to patient confidentiality concerns and institutional data protection policies. Additionally, the study is single-center with a limited sample size, and there is no formal data-sharing infrastructure or repository in place for this project.
Started Sep 2025 (actual). Primary completion is estimated for Feb 2026, 5 months after the start.
Of 392 non-industry observational studies under Pain, Postoperative, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 32. This study's planned 5 months is below that.
Counting every sponsor, half of 396 studies reached it within 13 months; a quarter within 6 and three quarters within 33.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital Central de la Defensa Gómez Ulla